06 Oct 2025
Strengthening global pandemic preparedness
Established with a visionary gift from international businessman and philanthropist Mr Geoffrey Cumming, a global initiative is driving revolutionary research into lifesaving disease treatments
The Cumming Global Centre for Pandemic Therapeutics brings together top researchers from around the world to ensure that when the next pandemic inevitably strikes, we can rapidly develop effective treatments and save millions of lives.
Speed and agility are key to a successful pandemic response. By focusing on developing ‘plug and play’ platform technologies that can be applied in any pandemic scenario, no matter the pathogen, the Cumming Global Centre aims to ensure scientists can quickly pivot to new pathogens as they emerge, and develop therapeutics in much shorter timeframes than currently possible.
Meet two researchers working on pioneering new approaches to treating infectious diseases.
Opening powerful possibilities for coronavirus treatments
Dr Shane Devine and his team at the WEHI are focused on new treatment options for coronaviruses – the large family of respiratory viruses that cause illnesses ranging from the common cold to pneumonia and COVID-19.
Dr Shane Devine (left) and his colleagues Dr Marcel Doerflinger and Prof David Komander.
Airborne illnesses are particularly difficult to control, making coronaviruses a likely source of the next pandemic. Dr Devine says, "An effective treatment for coronaviruses would completely change pandemic management.”
Dr Devine’s project specifically aims to inhibit the papain-like protease (PLpro), an enzyme that plays a key part in the replication of coronaviruses. In a world-first, Dr Devine’s team has developed small molecules that target PLpro across diverse coronavirus varieties. Early tests have shown promising results.
The ability to inhibit PLpro activity could yield therapeutics that target multiple strains of a virus, which would be an invaluable resource in combating novel pathogens as they change over time.
"We are making PLpro inhibitors that will literally stop coronavirus in its tracks,” Dr Devine said.
Learn more about Dr Devine's research here.
Harnessing the body’s natural immune response
Dr Annabell Bachem from the Peter Doherty Institute of Infection and Immunity – a joint venture between the University of Melbourne and Royal Melbourne Hospital – is leading a groundbreaking study on programmed cell death. This natural response causes infected cells to self-destruct to prevent disease from spreading in the body. By studying how pathogens evade or suppress this defence mechanism, Dr Bachem’s research aims to apply therapeutics that can trigger programmed cell death, stopping pathogens from replicating, and reducing the severity and duration of illness.
Dr Annabell Bachem (right) and Dr Sven Engel working in the lab.
Leveraging the body’s natural response – rather than targeting specific pathogens – means this versatile approach could potentially be applied to new pandemic threats. Dr Bachem hopes it will also lead to broad-spectrum therapies that can be used to treat a variety of viral and bacterial diseases, not just a single virus.
We might develop a therapy that helps us with not just one pandemic, but potentially the next five pandemics.
Learn more about Dr Bachem's research here.
The security to take risks
These researchers are able to pursue lifesaving breakthroughs with philanthropically supported Foundation Grants from the Cumming Global Centre. In a funding landscape that unfortunately often rewards low-risk research, where profitability and incremental progress is often prioritised over major discoveries, the Cumming Global Centre’s unique, mission-driven approach encourages innovation and pursuit of transformative projects that will have the greatest benefit to humanity. Long-term support frees the best scientific minds from onerous funding applications, to focus on research that will fundamentally change the way we manage and treat infectious disease.
This article originally appeared in The Power of Purpose - the 2025 edition of the University of Melbourne's Annual Report to donors. Each year, the University of Melbourne celebrates the many donors and alumni who help change the trajectory of students’ lives, uncover life-changing discoveries and build impactful communities. You can view the full report here.
ABOUT Cumming Global Centre for Pandemic Therapeutics
A mission-driven, global research centre to enable rapid design and development of therapeutics for future pandemics. www.doherty.edu.au/cumming-global-centre-for-pandemic-therapeutics
Contact
The Peter Doherty Institute for Infection and Immunity
792 Elizabeth Street | Melbourne | Victoria | Australia | 3000
doherty-media@unimelb.edu.au
doherty.edu.au
Mitchell Blincoe
Marketing & Communications Manager
792 Elizabeth Street, Melbourne 3000
mitchell.blincoe@unimelb.edu.au
+61 (0) 427 801 843
Source: https://www.doherty.edu.au/news-events/news/strengthening-global-pandemic-preparedness
"Reproduced with permission - The Peter Doherty Institute for Infection and Immunity"
The Peter Doherty Institute for Infection and Immunity
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News
|
